Petros Pharmaceuticals Ownership | Who Owns Petros Pharmaceuticals?

Petros Pharmaceuticals Ownership Summary

Petros Pharmaceuticals is owned by 3.35% institutional investors, and 96.65% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.36% of its assets in Petros Pharmaceuticals shares.

PTPI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Petros Pharmaceuticals	3.35%	-	96.65%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Specialty & Generic Drug Manufacturers Stocks	34.90%	10.53%	54.58%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2022	13	-7.14%	693,567	3.04%	3	31.65%	4	-33.33%	1	-50.00%
Jun 30, 2022	14	-26.32%	673,120	-19.27%	3	20.03%	6	-40.00%	2	-
Mar 31, 2022	19	-9.52%	833,814	-22.46%	4	4.13%	10	-33.33%	2	-33.33%
Dec 31, 2021	21	40.00%	1,075,312	32.37%	9	17.74%	15	400.00%	3	-40.00%
Sep 30, 2021	15	-16.67%	812,328	-15.67%	7	9.53%	3	-70.00%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	35.68K	0.36%	-6.87K
Vanguard Institutional Extnd Mkt Idx Tr	31.81K	0.32%	-
Fidelity Series Total Market Index	1.16K	0.01%	-
Fidelity Nasdaq Composite Index	674.00	0.01%	-
NT Ext Equity Mkt Idx Fd - L	510.00	0.01%	-
Northern Trust Extended Eq Market Idx	510.00	0.01%	-
SSgA U.S. Extended Market Index Class I	190.00	0.00%	-
State St US Extended Mkt Indx NL Cl C	190.00	0.00%	-
NT Ext Equity Mkt Idx Fd - NL	118.00	0.00%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	95.00	0.00%	-

Recent Insider Transactions

Date	Name	Activity	Value
Dec 22, 2021	SHULMAN JOHN D	Buy	$500.00K
Dec 22, 2021	SHULMAN JOHN D	Buy	$382.65K
Nov 29, 2021	SHULMAN JOHN D	Buy	$1.50M
Nov 29, 2021	SHULMAN JOHN D	Buy	$1.31M
Oct 18, 2021	SHULMAN JOHN D	Buy	$2.85M

Insider Transactions Trends

Date	Buy	Sell
2023 Q2	-	-
2023 Q1	-	-
2022 Q2	-	-
2021 Q4	6	-
2021 Q2	-	-

PTPI Ownership FAQ

Who Owns Petros Pharmaceuticals?

Petros Pharmaceuticals shareholders are primarily institutional investors at 3.35%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Petros Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Petros Pharmaceuticals falls below.

Does Blackrock own Petros Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Petros Pharmaceuticals.

Who is the top mutual fund holder of Petros Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Petros Pharmaceuticals shares, with 0.36% of its total shares outstanding invested in 35.68K Petros Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools